AIxCrypto Holdings, Inc.AIXC

$1.46+0.03 (+2.10%)

NASDAQHealthcare24:00 UTC

Company snapshot

Market Cap

$11M

Micro-cap

+89%

2017 — today

10-Year Price

-100%

2016 — today

52-Week Range

$0.96$6.01

Current $1.46· 10%

AIxCrypto Holdings, Inc. is a clinical-stage biopharmaceutical company committed to discovering and developing innovative treatments for both adult and pediatric oncology. Its leading investigational therapeutic, QN-302, is a small molecule G-quadruplexes (G4)-selective transcription inhibitor currently progressing through Phase I clinical trials for pancreatic cancer and a range of other solid tumors. The firm is also advancing Pan-RAS, a preclinical-stage program targeting advanced solid tumors. Founded in 1996 and headquartered in Carlsbad, California, the company rebranded from Qualigen Therapeutics, Inc. to AIxCrypto Holdings, Inc. in November 2025.

Valuation in context

P/E ratio

-0.2

N/A

Not meaningful — company is unprofitable

P/B ratio

0.5

Below average

Below the 10-year average

FCF Yield

-87.6%

Historically high

Historically high relative to the last 10 years

Free · No credit card needed

Get alerted when AIXC is cheap

Set a free alert — we'll push you when P/E, yield, or other metrics cross a historical threshold.